LTPA2018005I1 - Farmacinė kompozicija - Google Patents

Farmacinė kompozicija

Info

Publication number: LTPA2018005I1
Authority: LT; Lithuania
Prior art keywords: pharmaceutical composition; pharmaceutical; composition
Prior art date: 2007-03-29

Application number

LTPA2018005C

Other languages

English (en)

Original Assignee

Daiichi Sankyo Company, Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-03-29

Filing date

2018-01-25

Publication date

2018-02-12

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39875378&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LTPA2018005(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2018-01-25 Application filed by Daiichi Sankyo Company, Limited filed Critical Daiichi Sankyo Company, Limited

2018-02-12 Publication of LTPA2018005I1 publication Critical patent/LTPA2018005I1/lt

2018-11-12 Publication of LTC2140867I2 publication Critical patent/LTC2140867I2/lt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oil, Petroleum & Natural Gas (AREA)
Biochemistry (AREA)
Inorganic Chemistry (AREA)
Biophysics (AREA)
Cardiology (AREA)
Hematology (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

LTPA2018005C 2007-03-29 2018-01-25 Farmacinė kompozicija LTC2140867I2 (lt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2007087327		2007-03-29
PCT/JP2008/000791 WO2008129846A1 (ja)	2007-03-29	2008-03-28	医薬組成物

Publications (2)

Publication Number	Publication Date
LTPA2018005I1 true LTPA2018005I1 (lt)	2018-02-12
LTC2140867I2 LTC2140867I2 (lt)	2018-11-12

Family

ID=39875378

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
LTEP08720658.7T LT2140867T (lt)	2007-03-29	2008-03-28	Farmacinė kompozicija
LTPA2018005C LTC2140867I2 (lt)	2007-03-29	2018-01-25	Farmacinė kompozicija

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
LTEP08720658.7T LT2140867T (lt)	2007-03-29	2008-03-28	Farmacinė kompozicija

Country Status (28)

Country	Link
US (3)	US20100081685A1 (lt)
EP (1)	EP2140867B2 (lt)
JP (2)	JP4463875B2 (lt)
KR (1)	KR101424843B1 (lt)
CN (2)	CN101652139A (lt)
AU (1)	AU2008241982B2 (lt)
BR (1)	BRPI0809205B8 (lt)
CA (1)	CA2680039C (lt)
CO (1)	CO6220955A2 (lt)
CY (1)	CY1119377T1 (lt)
DK (1)	DK2140867T4 (lt)
ES (1)	ES2644803T5 (lt)
FI (1)	FI2140867T4 (lt)
HR (1)	HRP20171384T4 (lt)
HU (2)	HUE035990T2 (lt)
IL (2)	IL200790A (lt)
LT (2)	LT2140867T (lt)
MX (2)	MX2009010474A (lt)
MY (1)	MY149356A (lt)
NO (1)	NO20093008L (lt)
NZ (2)	NZ597109A (lt)
PL (1)	PL2140867T5 (lt)
PT (1)	PT2140867T (lt)
SG (1)	SG179497A1 (lt)
SI (1)	SI2140867T2 (lt)
TW (1)	TWI409064B (lt)
WO (1)	WO2008129846A1 (lt)
ZA (2)	ZA200906182B (lt)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2680039C (en)	2007-03-29	2015-05-26	Daiichi Sankyo Company, Limited	Pharmaceutical composition comprising edoxaban, an anticoagulant
BRPI0923109A8 (pt)	2008-12-17	2016-06-07	Daiichi Sankyo Co Ltd	método para a produção de derivados de diamina
EP2374456B1 (en) *	2008-12-19	2016-08-03	Daiichi Sankyo Company, Limited	Edoxaban dosage regime
WO2010082531A1 (ja)	2009-01-13	2010-07-22	第一三共株式会社	活性化血液凝固因子阻害剤
WO2010104078A1 (ja)	2009-03-10	2010-09-16	第一三共株式会社	ジアミン誘導体の製造方法
JP5652879B2 (ja)	2009-03-13	2015-01-14	第一三共株式会社	光学活性なジアミン誘導体の製造方法
EA201171329A1 (ru) *	2009-04-30	2012-05-30	Такеда Фармасьютикал Компани Лимитед	Твердый препарат
CN102481296A (zh)	2009-06-18	2012-05-30	第一三共株式会社	溶解性改善的药用组合物
EP2540317A4 (en) *	2010-02-22	2014-04-16	Daiichi Sankyo Co Ltd	SOLID PREPARATION WITH DELAYED RELEASE FOR ORAL ADMINISTRATION
EP2540318B1 (en) *	2010-02-22	2018-10-24	Daiichi Sankyo Company, Limited	Sustained-release solid preparation for oral use
JP5714562B2 (ja) *	2010-02-22	2015-05-07	第一三共株式会社	経口用徐放性固形製剤
ES2560955T3 (es) *	2010-03-19	2016-02-23	Daiichi Sankyo Company, Limited	Cristal de derivado de diamina y procedimiento de producción del mismo
EP2548556B1 (en) *	2010-03-19	2016-08-10	Daiichi Sankyo Company, Limited	Method for improving dissolvability of anticoagulant
TWI630209B (zh)	2010-07-02	2018-07-21	第一三共股份有限公司	光學活性二胺衍生物之鹽的製造方法
CN103732227B (zh) *	2011-08-10	2017-04-12	第一三共株式会社	含有二胺衍生物的药物组合物
WO2013026553A1 (en)	2011-08-22	2013-02-28	Ratiopharm Gmbh	Composition comprising edoxaban
CA2883077C (en)	2012-09-03	2017-03-07	Daiichi Sankyo Company, Limited	Hydromorphone hydrochloride-containing oral sustained-release pharmaceutical composition
JP6227352B2 (ja) *	2012-09-27	2017-11-08	株式会社三和化学研究所	アナグリプチン又はその塩を含有する固形製剤
JP6379044B2 (ja) *	2013-01-31	2018-08-22	沢井製薬株式会社	テルミサルタンとヒドロクロロチアジドとを含有する多層錠剤
TW201521794A (zh) *	2013-11-12	2015-06-16	Daiichi Sankyo Co Ltd	錠劑
US20170022220A1 (en) *	2014-02-25	2017-01-26	Daiichi Sankyo Company, Limited	High-purity crystals of active blood coagulation factor x (fxa) inhibitor
WO2016104678A1 (ja) *	2014-12-26	2016-06-30	第一三共株式会社	線溶を促進するための医薬組成物
CN107405342B (zh) *	2015-12-24	2021-05-14	江苏恒瑞医药股份有限公司	一种含有二胺衍生物或其盐的固体药物组合物
EP3429377B1 (en) *	2016-03-16	2020-09-09	Golden Omega Norway AS	Powders and tablets comprising omega-3 fatty acid derivatives and method for their production
JP6673798B2 (ja) *	2016-10-12	2020-03-25	日本化薬株式会社	カペシタビンを有効成分とするフィルムコート医薬製剤
TWI812602B (zh)	2016-12-01	2023-08-21	日商第一三共股份有限公司	含二胺衍生物之口腔崩散錠及其製造方法
TWI826474B (zh)	2018-06-27	2023-12-21	日商第一三共股份有限公司	包含二胺衍生物之顆粒劑、以及其用途及製造方法
KR102222774B1 (ko) *	2018-07-27	2021-03-04	보령제약 주식회사	에독사반을 포함하는 약학적 제제 및 이의 제조방법
KR20200079957A (ko)	2018-12-26	2020-07-06	한국콜마주식회사	에독사반을 함유한 경구용 의약 조성물 및 그의 제조방법
KR102514961B1 (ko)	2019-03-05	2023-03-28	주식회사 파마코스텍	에독사반 벤젠술폰산염 1 수화물 결정형 및 그 제조방법
EP3744320A1 (en)	2019-05-29	2020-12-02	Alfred E. Tiefenbacher (GmbH & Co. KG)	Pharmaceutical tablet composition comprising edoxaban
KR20210048632A (ko)	2019-10-23	2021-05-04	한미약품 주식회사	에독사반 유리 염기 함유 제약 조성물
KR102333564B1 (ko)	2019-11-28	2021-12-01	동방에프티엘(주)	광학 활성 다이아민 유도체 및 티아졸 유도체의 생산을 위한 새로운 합성경로
KR102090912B1 (ko)	2019-12-18	2020-03-18	유니셀랩 주식회사	신규한 결정형 형태의 에독사반 및 이의 제조방법
EP3838267A1 (en)	2019-12-19	2021-06-23	Biohorm, S.L.	Edoxaban tablets
KR102513519B1 (ko)	2020-06-08	2023-03-23	주식회사 파마코스텍	신규한 에독사반 벤젠술폰산염 1 수화물의 제조방법
KR102222784B1 (ko)	2020-09-17	2021-03-04	유니셀랩 주식회사	신규한 에독사반 헤미에틸렌다이설퍼닉산 염 일수화물
WO2022129535A1 (en)	2020-12-18	2022-06-23	Krka, D.D., Novo Mesto	Edoxaban formulation containing no sugar alcohols
KR102518204B1 (ko)	2022-02-18	2023-04-05	주식회사 엔비피헬스케어	신규한 에독사반 프로필렌글리콜 용매화물
AU2023390819A1 (en)	2022-12-09	2025-07-03	Synthon B.V.	Formulation comprising edoxaban and preparation thereof
JP7352248B1 (ja) *	2023-03-27	2023-09-28	学校法人藤田学園	抗がん剤

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4361545A (en) *	1979-05-21	1982-11-30	Rowell Laboratories, Inc.	Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion
JP2814513B2 (ja) *	1988-02-03	1998-10-22	吉富製薬株式会社	溶出性の改良された製剤組成物
JP2642486B2 (ja) *	1989-08-04	1997-08-20	田辺製薬株式会社	難溶性薬物の超微粒子化法
US5149855A (en)	1989-12-26	1992-09-22	Mitsubishi Rayon Co., Ltd.	Process for racemizing optically active carboxylic acid esters
US5055600A (en)	1990-04-24	1991-10-08	Rockwell International Corporation	Glycidyl azide polymer (gap) synthesis by molten salt method
US5506248A (en)	1993-08-02	1996-04-09	Bristol-Myers Squibb Company	Pharmaceutical compositions having good dissolution properties
IL110376A (en) *	1993-08-02	1998-08-16	Bristol Myers Squibb Co	Pharmaceutical compositions containing ifetroban salts and methods for the preparation thereof
US5677469A (en)	1995-05-18	1997-10-14	Sepracor, Inc.	Process for resolving chiral acids with 1-aminoindan-2-ols
JPH09309829A (ja) *	1996-05-22	1997-12-02	Taiyo Yakuhin Kogyo Kk	ニトレンジピン含有経口投与製剤およびその製造法
US5958453A (en) *	1996-10-31	1999-09-28	Takeda Chemical Industries, Ltd.	Solid pharmaceutical preparation with improved buccal disintegrability and/or dissolubility
JPH11180899A (ja)	1997-12-15	1999-07-06	Mitsui Chem Inc	活性メチレンアルキル化化合物の製造法
JP3680203B2 (ja)	1999-06-01	2005-08-10	東洋化成工業株式会社	４−アセチルアミノベンゼンスルホニルアジドの製造方法
JP4044709B2 (ja) *	1999-11-19	2008-02-06	信越化学工業株式会社	水系フィルムコーティング剤及び経口固形製剤
JP2001151724A (ja)	1999-11-19	2001-06-05	Kuraray Co Ltd	光学活性な２，２，４−トリメチル−３−シクロヘキセンカルボン酸の製造方法
TWI290136B (en)	2000-04-05	2007-11-21	Daiichi Seiyaku Co	Ethylenediamine derivatives
ES2307653T3 (es)	2000-10-24	2008-12-01	Ajinomoto Co., Inc.	Preparaciones que contienen nateglinida.
DE10106971A1 (de) *	2001-02-15	2002-08-29	Boehringer Ingelheim Pharma	Arzneimittelformulierung die einen muskarinischen Agonisten enthält
US20020160048A1 (en) *	2001-02-15	2002-10-31	Karoline Bechtold-Peters	Medical formulation containing a muscarinic agonist
KR100908418B1 (ko) *	2001-06-20	2009-07-21	액티버스 파마 컴퍼니 리미티드	퀴놀리논 유도체 의약 조성물 및 그의 제조 방법
CN1826333B (zh)	2001-06-20	2012-12-26	第一三共株式会社	二胺衍生物
JP3939601B2 (ja) *	2001-06-20	2007-07-04	株式会社アクティバスファーマ	キノリノン誘導体医薬組成物及びその製造方法
US7365205B2 (en)	2001-06-20	2008-04-29	Daiichi Sankyo Company, Limited	Diamine derivatives
BR0211565A (pt)	2001-08-09	2004-06-29	Daiichi Seiyaku Co	Derivados de diamina
MY140561A (en) *	2002-02-20	2009-12-31	Nycomed Gmbh	Dosage form containing pde 4 inhibitor as active ingredient
WO2003097102A1 (fr) *	2002-05-22	2003-11-27	Shionogi & Co., Ltd.	Preparation pharmaceutique dans laquelle la propriete de dissolution d'un medicament faiblement soluble dans l'eau est amelioree
ES2393996T3 (es)	2002-12-25	2013-01-04	Daiichi Sankyo Company, Limited	Derivados de diaminociclohexano antitrombóticos
EP1613288B1 (en) *	2003-04-08	2008-11-19	Novartis AG	Solid pharmaceutical compositions comprising a s1p receptor agonist and a sugar alcohol
JP4606258B2 (ja) *	2003-06-17	2011-01-05	協和発酵キリン株式会社	塩酸ベニジピン含有医薬組成物
CN102166212A (zh)	2003-06-17	2011-08-31	协和发酵麒麟株式会社	使盐酸贝尼地平从片剂中迅速溶出的方法
EP1683800A4 (en)	2003-11-12	2010-08-25	Daiichi Sankyo Co Ltd	PROCESS FOR PRODUCING THIAZOLE DERIVATIVE
DE10355461A1 (de)	2003-11-27	2005-06-23	Bayer Healthcare Ag	Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
AR057035A1 (es)	2005-05-25	2007-11-14	Progenics Pharm Inc	SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
KR101361441B1 (ko)	2005-09-16	2014-02-10	다이이찌 산쿄 가부시키가이샤	광학활성인 디아민 유도체 및 그의 제조방법
JP4703333B2 (ja)	2005-09-26	2011-06-15	エヌ・ティ・ティ・ソフトウェア株式会社	電子メール処理プログラム
CA2680039C (en)	2007-03-29	2015-05-26	Daiichi Sankyo Company, Limited	Pharmaceutical composition comprising edoxaban, an anticoagulant
TW200909437A (en)	2007-06-21	2009-03-01	Daiichi Sankyo Co Ltd	Process for the preparation of diamine-derivatives
CN102317248A (zh)	2008-12-12	2012-01-11	第一三共株式会社	光学活性羧酸的生产方法
BRPI0923109A8 (pt)	2008-12-17	2016-06-07	Daiichi Sankyo Co Ltd	método para a produção de derivados de diamina
EP2374456B1 (en)	2008-12-19	2016-08-03	Daiichi Sankyo Company, Limited	Edoxaban dosage regime
WO2010082531A1 (ja)	2009-01-13	2010-07-22	第一三共株式会社	活性化血液凝固因子阻害剤
WO2010104078A1 (ja)	2009-03-10	2010-09-16	第一三共株式会社	ジアミン誘導体の製造方法
JP5652879B2 (ja)	2009-03-13	2015-01-14	第一三共株式会社	光学活性なジアミン誘導体の製造方法
WO2010131663A1 (ja)	2009-05-15	2010-11-18	第一三共株式会社	オキサミド誘導体
CN102481296A (zh)	2009-06-18	2012-05-30	第一三共株式会社	溶解性改善的药用组合物
JP2011051672A (ja)	2009-08-31	2011-03-17	Ihi Corp	ラック棚及びラック棚の組立て方法
ES2560955T3 (es)	2010-03-19	2016-02-23	Daiichi Sankyo Company, Limited	Cristal de derivado de diamina y procedimiento de producción del mismo
US20130158069A1 (en)	2011-12-14	2013-06-20	Daiichi Sankyo Company, Limited	Preventive and/or therapeutic agent for thromboembolism in thromboembolism patient with severe renal impairment

2008
- 2008-03-28 CA CA2680039A patent/CA2680039C/en active Active
- 2008-03-28 ES ES08720658T patent/ES2644803T5/es active Active
- 2008-03-28 HR HRP20171384TT patent/HRP20171384T4/hr unknown
- 2008-03-28 PL PL08720658.7T patent/PL2140867T5/pl unknown
- 2008-03-28 LT LTEP08720658.7T patent/LT2140867T/lt unknown
- 2008-03-28 JP JP2009510780A patent/JP4463875B2/ja active Active
- 2008-03-28 HU HUE08720658A patent/HUE035990T2/en unknown
- 2008-03-28 BR BRPI0809205A patent/BRPI0809205B8/pt active IP Right Grant
- 2008-03-28 SG SG2012018826A patent/SG179497A1/en unknown
- 2008-03-28 AU AU2008241982A patent/AU2008241982B2/en active Active
- 2008-03-28 TW TW97111503A patent/TWI409064B/zh active
- 2008-03-28 NZ NZ59710908A patent/NZ597109A/xx unknown
- 2008-03-28 FI FIEP08720658.7T patent/FI2140867T4/fi active
- 2008-03-28 PT PT87206587T patent/PT2140867T/pt unknown
- 2008-03-28 DK DK08720658.7T patent/DK2140867T4/da active
- 2008-03-28 MX MX2009010474A patent/MX2009010474A/es active IP Right Grant
- 2008-03-28 CN CN200880010935A patent/CN101652139A/zh active Pending
- 2008-03-28 KR KR1020097019320A patent/KR101424843B1/ko active Active
- 2008-03-28 SI SI200831863T patent/SI2140867T2/sl unknown
- 2008-03-28 EP EP08720658.7A patent/EP2140867B2/en active Active
- 2008-03-28 NZ NZ579725A patent/NZ579725A/en unknown
- 2008-03-28 MY MYPI20093689 patent/MY149356A/en unknown
- 2008-03-28 WO PCT/JP2008/000791 patent/WO2008129846A1/ja active Application Filing
- 2008-03-28 CN CN201410468293.6A patent/CN104324015B/zh active Active
- 2008-03-28 MX MX2011010260A patent/MX351987B/es unknown
2009
- 2009-09-07 ZA ZA2009/06182A patent/ZA200906182B/en unknown
- 2009-09-07 IL IL200790A patent/IL200790A/en not_active IP Right Cessation
- 2009-09-16 NO NO20093008A patent/NO20093008L/no unknown
- 2009-09-28 CO CO09106060A patent/CO6220955A2/es not_active Application Discontinuation
- 2009-09-29 US US12/569,057 patent/US20100081685A1/en not_active Abandoned
2010
- 2010-01-18 JP JP2010007969A patent/JP2010090168A/ja active Pending
- 2010-08-18 ZA ZA2010/05906A patent/ZA201005906B/en unknown
2012
- 2012-05-16 IL IL219829A patent/IL219829A0/en unknown
2013
- 2013-08-16 US US13/968,776 patent/US9149532B2/en active Active
2015
- 2015-08-12 US US14/825,036 patent/US9707296B2/en active Active
2017
- 2017-09-20 CY CY20171100990T patent/CY1119377T1/el unknown
2018
- 2018-01-25 LT LTPA2018005C patent/LTC2140867I2/lt unknown
- 2018-02-12 HU HUS1800007C patent/HUS1800007I1/hu unknown

Also Published As

Publication number	Publication date
FI2140867T4 (fi)	2023-09-14
IL200790A (en)	2014-06-30
US20130337064A1 (en)	2013-12-19
SG179497A1 (en)	2012-04-27
CA2680039C (en)	2015-05-26
RU2470637C2 (ru)	2012-12-27
BRPI0809205B8 (pt)	2021-05-25
LT2140867T (lt)	2017-12-11
PL2140867T5 (pl)	2023-10-30
JP4463875B2 (ja)	2010-05-19
BRPI0809205B1 (pt)	2019-09-03
IL200790A0 (en)	2010-05-17
RU2009139917A (ru)	2011-05-10
EP2140867B2 (en)	2023-08-16
CN101652139A (zh)	2010-02-17
CN104324015A (zh)	2015-02-04
TW200845972A (en)	2008-12-01
NZ597109A (en)	2013-01-25
AU2008241982A1 (en)	2008-10-30
DK2140867T4 (da)	2023-09-25
MX2009010474A (es)	2009-10-19
US20150342938A1 (en)	2015-12-03
SI2140867T2 (sl)	2023-10-30
KR101424843B1 (ko)	2014-08-13
ES2644803T5 (es)	2024-02-26
JP2010090168A (ja)	2010-04-22
NO20093008L (no)	2009-09-30
NZ579725A (en)	2012-02-24
HRP20171384T4 (hr)	2024-02-16
KR20090122950A (ko)	2009-12-01
HUS1800007I1 (hu)	2018-03-28
IL219829A0 (en)	2012-06-28
CO6220955A2 (es)	2010-11-19
HUE035990T2 (en)	2018-05-28
JPWO2008129846A1 (ja)	2010-07-22
ZA201005906B (en)	2012-05-30
EP2140867B1 (en)	2017-08-30
ZA200906182B (en)	2010-11-24
AU2008241982B2 (en)	2013-02-21
CA2680039A1 (en)	2008-10-30
US9707296B2 (en)	2017-07-18
EP2140867A4 (en)	2013-07-03
MX351987B (es)	2017-11-03
SI2140867T1 (sl)	2017-12-29
PT2140867T (pt)	2017-10-04
ES2644803T3 (es)	2017-11-30
CN104324015B (zh)	2018-08-28
DK2140867T3 (en)	2017-10-09
LTC2140867I2 (lt)	2018-11-12
CY1119377T1 (el)	2018-02-14
US9149532B2 (en)	2015-10-06
WO2008129846A1 (ja)	2008-10-30
EP2140867A1 (en)	2010-01-06
PL2140867T3 (pl)	2017-12-29
MY149356A (en)	2013-08-30
US20100081685A1 (en)	2010-04-01
HRP20171384T1 (hr)	2017-11-17
TWI409064B (zh)	2013-09-21
BRPI0809205A2 (pt)	2014-09-02

Publication	Publication Date	Title
LTPA2018005I1 (lt)	2018-02-12	Farmacinė kompozicija
LTPA2018014I1 (lt)	2018-12-10	Farmacinė kompozicija 514
BRPI0721651A2 (pt)	2014-04-01	Composição farmacêutica
BRPI0715712A2 (pt)	2014-06-24	Composição farmacêutica
RU2493831C3 (ru)	2017-06-08	Фармацевтические композиции
BRPI0719393A2 (pt)	2015-03-31	Composição farmacêutica
DK2120884T3 (da)	2011-02-07	Farmaceutisk sammensætning
BRPI0820381A2 (pt)	2015-05-19	Formulações farmacêuticas
EP2191826A4 (en)	2010-09-15	PHARMACEUTICAL COMPOSITION
BRPI0813775A2 (pt)	2015-01-06	Composição
ATE528048T1 (de)	2011-10-15	Schweisshemmende/desodorierende zusammensetzung
BRPI0720234A2 (pt)	2013-12-24	Composição farmacêutica
BRPI0716445A2 (pt)	2013-09-17	composiÇço farmacÊutica
DK2285413T3 (da)	2012-08-27	Farmaceutisk sammensætning
DK2966175T3 (da)	2019-07-01	Farmaceutiske sammensætninger indeholdende cortexolon-17-alpha-propionat
PT2209464E (pt)	2014-09-05	Composição farmacêutica antimalárica
BRPI0810557A2 (pt)	2016-07-19	composição
EP2236149A4 (en)	2012-12-26	MEDICAL COMPOSITION
BRPI0811274A2 (pt)	2014-10-07	Composição
BRPI0921313A2 (pt)	2015-12-29	composição farmaucêutica
EP2197828A4 (en)	2011-09-21	FULLERENE MULTI-ADDUCT COMPOSITIONS
BRPI0820198A2 (pt)	2019-09-24	composições farmacêuticas
BRPI0811002A2 (pt)	2015-01-27	Composição biofertilizante
BRPI0820960A2 (pt)	2017-05-09	composição
BRPI0912171A2 (pt)	2017-10-31	composição farmacêutica